×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Epperly Melissa B,

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ROIVRoivant Sciences Ltd.Epperly Melissa B,DirectorSep 12, 2024Option Exercise$12.124,24551,44936,424Sep 16, 2024, 09:00 PM
ROIVRoivant Sciences Ltd.Epperly Melissa B,DirectorApr 24, 2024Option Exercise$10.901231,34122,561Apr 26, 2024, 09:01 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerFeb 12, 2024Sale$11.442,57329,435451,449Feb 12, 2024, 08:22 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerFeb 02, 2024Sale$11.548,669100,040454,022Feb 05, 2024, 07:12 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerOct 04, 2023Sale$19.505,482106,926388,579Oct 06, 2023, 07:18 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerFeb 13, 2023Sale$20.422,62453,594397,275Feb 14, 2023, 07:10 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerFeb 14, 2023Sale$19.985,227104,411392,048Feb 14, 2023, 07:10 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerApr 04, 2022Sale$50.0917,080855,522256,400Apr 05, 2022, 06:53 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerFeb 23, 2022Sale$49.101,91393,921265,196Feb 23, 2022, 08:12 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerOct 02, 2021Option Exercise$67.1317,0801,146,580250,002Oct 04, 2021, 09:16 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerAug 18, 2021Buy$52.001,32668,948258,400Aug 20, 2021, 12:59 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerAug 19, 2021Buy$52.008,285430,800266,685Aug 20, 2021, 12:59 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerJul 01, 2021Sale$51.273,083158,054259,457Jul 06, 2021, 08:01 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerJun 01, 2021Sale$54.053,083166,641260,357Jun 02, 2021, 08:26 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerApr 05, 2021Sale$43.3917,107742,323280,347Apr 06, 2021, 05:46 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerMar 01, 2021Sale$41.673,083128,482283,430Mar 03, 2021, 04:35 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerFeb 01, 2021Sale$37.563,083115,805271,896Feb 03, 2021, 05:56 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerJan 04, 2021Sale$51.913,083160,034276,879Jan 06, 2021, 08:24 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerDec 04, 2020Sale$50.987,220368,097288,020Dec 08, 2020, 08:38 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerDec 07, 2020Sale$53.526,464345,963284,024Dec 08, 2020, 08:38 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerDec 02, 2020Sale$51.473,083158,681293,746Dec 03, 2020, 05:56 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerApr 07, 2020Buy$18.0020,000360,000297,529Nov 25, 2020, 08:35 PM
ZNTLZentalis Pharmaceuticals, Inc.Epperly Melissa B,Chief Financial OfficerNov 23, 2020Sale$46.583,083143,614294,746Nov 25, 2020, 08:35 PM